111 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
in the 3rd quarter.
- 19 -
Translation for reference purpose only
(6) Information on voting rights
1) Total number of shares
As of December 31, 2023 …
Classification
Number of shares
(Shares)
Number of voting rights (Units)
Description
Shares without voting rights
Shares with restricted voting rights
(Treasury
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
their voting rights. e. Cross-Shareholdings - Principle 1.4 The Company only holds shares of other companies with which it has business relationships … environment into consideration. The Company decides whether to exercise its voting rights on cross-shareholdings after conducting a comprehensive review
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
on voting rights
1) Total number of shares
As of September 30, 2023
Classification
Number of shares
(Shares)
Number of voting rights (Units … )
Description
Shares without voting rights
Shares with restricted voting rights
(Treasury stock and other)
Shares with restricted voting rights
(Others)
Shares
6-K
TAK
Takeda Pharmaceutical Co
1 Aug 23
Current report (foreign)
6:10am
-
Translation for reference purpose only
(6) Information on voting rights
1) Total number of shares
As of June 30, 2023
Classification
Number of shares …
(Shares)
Number of voting rights (Units)
Description
Shares without voting rights
Shares with restricted voting rights
(Treasury stock and other)
Shares
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
their voting rights. e. Cross-Shareholdings - Principle 1.4 The Company only holds shares of other companies with which it has business relationships … environment into consideration. The Company decides whether to exercise its voting rights on cross-shareholdings after conducting a comprehensive review
6-K
ff4ym9zfjoezgmr05t
3 Jul 23
Current report (foreign)
6:02am
S-8
EX-99.2
ebz6vxi
28 Jun 23
Registration of securities for employees
6:35am
6-K
EX-99.1
zaqm83 hdos
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
ion7c
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
bdy4rna nwkimx7
30 May 23
Current report (foreign)
6:11am
6-K
ggq yt2bbxlggp7b
11 May 23
Current report (foreign)
6:10am
6-K
rflej4n esjln6
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
fbboe
4 Nov 22
Current report (foreign)
6:01am
6-K
w10wae hwm
4 Aug 22
Current report (foreign)
6:07am
6-K
kc1ct6l
11 Jul 22
Current report (foreign)
6:05am
6-K
ci98h 6maq329
5 Jul 22
Current report (foreign)
6:09am
S-8
EX-99.1
tu2rw9h
29 Jun 22
Registration of securities for employees
6:13am